The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2015

Filed:

Dec. 19, 2011
Applicants:

Palma Rocchi, Marseilles, FR;

Virginie Baylot, Marseilles, FR;

Julie Acunzo, Marseilles, FR;

Claudia Andrieu, Marseilles, FR;

Maria Katsogiannou, Marseilles, FR;

Inventors:

Palma Rocchi, Marseilles, FR;

Virginie Baylot, Marseilles, FR;

Julie Acunzo, Marseilles, FR;

Claudia Andrieu, Marseilles, FR;

Maria Katsogiannou, Marseilles, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 45/06 (2006.01); C12N 15/113 (2010.01); A61K 31/337 (2006.01); A61K 31/713 (2006.01); A61K 39/395 (2006.01); A61N 5/10 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); C12N 15/1135 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); A61K 31/337 (2013.01); A61K 31/713 (2013.01); A61K 39/39558 (2013.01); A61N 5/10 (2013.01);
Abstract

The present invention concerns a TCTP antagonist, in particular a nucleic acid targeting an m RNA encoding Translationally-Controlled Tumor Protein (TCTP), wherein said nucleic acid is capable of reducing the amount of TCTP in cells, for use in the treatment or prevention of hormone-independent cancer or chemo-resistant cancer, such as an androgen-independent prostate cancer.


Find Patent Forward Citations

Loading…